M
Matthew Jaffa
Researcher at Harvard University
Publications - 19
Citations - 506
Matthew Jaffa is an academic researcher from Harvard University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 6, co-authored 6 publications receiving 438 citations.
Papers
More filters
Journal ArticleDOI
Body mass index, not dyslipidemia, is an independent predictor of survival in amyotrophic lateral sclerosis
TL;DR: It is found that dyslipidemia is not an independent predictor of survival in ALS, and BMI is an independent prognostic factor for survival after adjusting for markers of disease severity.
Journal ArticleDOI
Uric acid levels predict survival in men with amyotrophic lateral sclerosis
Sabrina Paganoni,May Zhang,Alejandro Quiroz Zárate,Matthew Jaffa,Hong Yu,Merit Cudkowicz,Anne-Marie Wills +6 more
TL;DR: It is demonstrated that serum uric acid is associated with prolonged survival in ALS, after adjusting for markers of disease severity, and this association was seen in male subjects only.
Journal ArticleDOI
SOD1 in Cerebral Spinal Fluid as a Pharmacodynamic Marker for Antisense Oligonucleotide Therapy
Leah K. Winer,Dushyanth Srinivasan,Seung J. Chun,David Lacomis,Matthew Jaffa,Anne M. Fagan,David M. Holtzman,Ed Wancewicz,C. Frank Bennett,Robert Bowser,Merit Cudkowicz,Timothy M. Miller +11 more
TL;DR: SOD1 in CSF may be an excellent pharmacodynamic marker for S OD1-lowering therapies because antisense oligonucleotide therapy lowers protein levels in the rat brain and rat CSF samples and because SOD1 levels inCSF samples from humans are stable over time.
Journal ArticleDOI
Anti-superoxide dismutase antibodies are associated with survival in patients with sporadic amyotrophic lateral sclerosis
Marka van Blitterswijk,Sunita Gulati,Elizabeth Smoot,Matthew Jaffa,Nancy E. Maher,Bradley T. Hyman,Adrian J. Ivinson,Clemens R. Scherzer,David A. Schoenfeld,Merit Cudkowicz,Robert H. Brown,Daryl A. Bosco +11 more
TL;DR: The association of longer survival with elevated levels of anti-SODox antibodies suggests that these antibodies may be protective, and implicate aberrantly modified forms of WT-Sod1 (e.g. oxidized SOD1) in SALS pathogenesis.
Journal ArticleDOI
Proposed BioRepository platform solution for the ALS research community
Alexander V. Sherman,Robert Bowser,Daniela L. Grasso,Breen Power,Carol Milligan,Matthew Jaffa,Merit Cudkowicz +6 more
TL;DR: This work has created one of the largest virtual collections of ALS-related specimens available to investigators studying ALS by developing a secure Web-based system to manage an inventory of multi-site BioRepository.